Monthly Archives: December 2014

Biothera Participates in Cancer Research UK Combinations Alliance

EAGAN, MN, December 18, 2014 — Biothera announced today that it has joined AstraZeneca, Astex Pharmaceuticals, Eli Lilly and Company, MedImmune and Verastem as the latest pharmaceutical partner in Cancer Research UK’s Combinations Alliance. The Combinations Alliance is a joint initiative between Cancer Research UK’s Centre for Drug Development, the Experimental Cancer Medicine Centre (ECMC) Network and select pharmaceutical companies and aims to develop novel...

Read More


Dr. Tanya Mayadas Joins Biothera’s Research Advisory Board

EAGAN, MN, December 18, 2014 — Biothera announced today that Tanya Mayadas, Ph.D. has joined its Research Advisory Board. Dr. Mayadas is a Professor of Pathology at Harvard Medical School, Boston, MA. She has a broad background in inflammation, with specific expertise in elucidating the neutrophil-dependent mechanisms of tissue injury in disease. Over the past 20 years, Dr. Mayadas’ research has focused on the role...

Read More


Dr. John Vasilakos Joins Biothera’s Research Advisory Board

EAGAN, MN — December 9, 2014 — John Vasilakos, Ph.D., an expert in innate immune modulation, has joined the Biothera Research Advisory Board, the company announced today. Dr. Vasilakos is the Senior Research Immunologist and Business Director of the Toll-Like Receptor (TLR) Agonists Program in 3M Company’s Drug Delivery Systems Division. For more than 20 years, he has focused on human immunology and has extensive...

Read More


New Data Strengthens Correlation Between Biomarker and Cancer Immunotherapeutic Imprime PGG

Research to be Presented at AACR Cancer Conference EAGAN, MN — December 2, 2014 — At the AACR Tumor Immunology and Immunotherapy: The Next Chapter conference today, Biothera will present data describing the presence and distribution of a biomarker that may predict the ability of subjects to respond to its immunotherapeutic Imprime PGG®. Imprime PGG is a novel innate immune cell modulator currently in late-stage...

Read More


Biothera to Present at Piper Jaffray Healthcare Conference

Biothera to Present at Piper Jaffray Healthcare Conference

Biothera to Present at Piper Jaffray Healthcare Conference EAGAN, MN — December 1, 2014 — Biothera announced today that its Chief Medical Officer Ada Braun, Ph.D., M.D., will present research on the company’s cancer immunotherapeutic Imprime PGG® at 11:50 am EST on December 3 at the Piper Jaffray Healthcare Conference. The event will take place at The New York Palace Hotel in New York City....

Read More